A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors (FLT)
A Pilot, Non-Therapeutic NeuroImaging Study of 18F-FLT in Pediatric Patients With Newly Diagnosed Central Nervous System Tumors
Sponsor: Boston Children's Hospital
Terminated
Large phase II opened to accue same patients
Other terminated trials from Boston Children's Hospital
A PHASE1 clinical study on Tumors of the Central Nervous System, this trial is terminated or withdrawn. The trial is conducted by Boston Children's Hospital and has accumulated 8 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Nov 2021 — Jul 2024 [monthly]
Terminated PHASE1
Phase: NA → PHASE1
-
Jan 2021 — Nov 2021 [monthly]
Terminated NA
-
Sep 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Sep 2020 [monthly]
Terminated NA
-
May 2018 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — May 2018 [monthly]
Terminated NA
First recorded
Mar 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Children's Hospital
- Dana-Farber Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .